GAMMA Investing’s Cross Country Healthcare CCRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$4.48K Buy
339
+82
+32% +$971 ﹤0.01% 3514
2026
Q1
$2.42K Buy
257
+116
+82% +$1.04K ﹤0.01% 3607
2025
Q4
$1.14K Sell
141
-898
-86% -$9.81K ﹤0.01% 3752
2025
Q3
$14.8K Sell
1,039
-841
-45% -$11.1K ﹤0.01% 2677
2025
Q2
$24.5K Sell
1,880
-131
-7% -$1.8K ﹤0.01% 2353
2025
Q1
$29.9K Sell
2,011
-358
-15% -$6.15K ﹤0.01% 2159
2024
Q4
$43K Sell
2,369
-5,174
-69% -$69.7K ﹤0.01% 1778
2024
Q3
$101K Buy
7,543
+1,865
+33% +$27.5K 0.01% 996
2024
Q2
$78.6K Buy
5,678
+4,892
+622% +$77.4K 0.01% 908
2024
Q1
$14.7K Sell
786
-534
-40% -$10.7K ﹤0.01% 1846
2023
Q4
$28.1K Buy
+1,320
New +$28.6K 0.01% 1266

Other funds holding CCRN

GAMMA Investing's CCRN Position: Q2 2026 in Review

GAMMA Investing increased its Cross Country Healthcare (CCRN) stake by 32% in Q2 2026, buying an estimated $971 and bringing the position to 339 shares worth $4.48K. The position accounts for ﹤0.01% of the portfolio, ranked #3514.

GAMMA Investing first reported a position in CCRN in Q4 2023 and has held it in 11 quarters since. The position peaked at $101K in Q3 2024. 19 funds tracked by Wall St. Rank hold CCRN as of Q2 2026.

  • GAMMA Investing held 339 shares of Cross Country Healthcare worth $4.48K as of Q2 2026.
  • GAMMA Investing bought 82 Cross Country Healthcare shares in Q2 2026, an estimated $971.
  • Cross Country Healthcare made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #3514 holding.
  • GAMMA Investing first reported a position in Cross Country Healthcare in Q4 2023 and has held it in 11 quarters since.
  • GAMMA Investing's Cross Country Healthcare position peaked at $101K in Q3 2024.
  • 19 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.